Form EFFECT Vanda Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 5, 2026 9:00 A.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burco Helps Drivers Lower Repair Costs with Replacement Side View Mirror Glass
- MemeToro vs MemeCore: Can Public Fair-Launch Code Give MemeToro the Stronger 2026 Story?
- American Rare Earths Reports Strong Initial Assay Results from 2026 Feasibility Drilling at Halleck Creek
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share